Jaguar Health, Inc. (JAGX) - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K, dated May 17, 2021, serves as a current report for Jaguar Health, Inc., a Delaware corporation. The filing announces the release of the Company's financial results for the first quarter of 2021. The Company's common stock trades on The Nasdaq Capital Market under the symbol JAGX.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. This document acts as a notification that the results have been issued via a press release (Exhibit 99.1), but the detailed financial data is not contained within the body of this 8-K form.
Material Changes
No material changes versus the prior comparable period are detailed in this specific filing text. The document references the Q1 2021 results but does not explicitly state the magnitude of changes or year-over-year comparisons.
Guidance, Outlook, and Risks
The filing includes a standard disclaimer stating that the information in Item 2.02 and the accompanying press release shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor subject to the liabilities of that section, unless expressly incorporated by reference. No specific guidance, outlook, or risk factors are detailed in the text of this 8-K.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 17, 2021) for actual Q1 2021 financial figures.
- Verify the specific revenue and net loss numbers for the quarter, as they are not listed in this summary document.
- Check for any forward-looking statements or updated guidance contained within the referenced press release.
- Confirm the Company's cash position and runway based on the detailed financial statements in the press release.